Physician
Geoffrey Trenkle DO a Professional Medical Corporation
Geoffrey Trenkle DO a Professional Medical Corporation was paid $7.67M by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is 99204, doctor's office visit, new patient (more involved) — 23% of everything it billed.
33Billing provider infoGEOFFREY TRENKLE DO A PROFESSIONAL MEDICAL CORPORATION
LOS ANGELES, CA 90033
LOS ANGELES, CA 90033
33aNPI1992124978assigned 04/07/2014
33bProvider typeOtolaryngology Physician
28Total paid$7.67M
24GClaims179,272
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Otolaryngology Physician providers in California
Rank by total paid#2 of 168
Median peer was paid$67K
This provider vs. median114×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,918 | $335K | |
| 2019 | 9,852 | $534K | |
| 2020 | 10,669 | $346K | |
| 2021 | 20,695 | $607K | |
| 2022 | 56,267 | $1.77M | |
| 2023 | 34,522 | $1.86M | |
| 2024incomplete | 39,349 | $2.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 23% | 25,396 | 25,347 | $1.79M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 22,331 | 20,966 | $1.34M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.6% | 20,806 | 19,651 | $739K |
| 31231 | 9.3% | 8,619 | 8,487 | $710K | |
| 31575 | 3.5% | 4,715 | 4,655 | $265K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.4% | 8,550 | 6,863 | $258K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.0% | 6,705 | 6,520 | $233K |
| 95024 | 2.7% | 1,519 | 1,515 | $206K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.5% | 8,114 | 6,185 | $195K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.5% | 3,501 | 3,481 | $195K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.5% | 6,984 | 5,416 | $189K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2.0% | 2,156 | 2,113 | $156K |
57 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.9% | 1,731 | $150K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 3,722 | $135K |
| 31237 | 1.7% | 1,019 | $127K | |
| 92557 | 1.5% | 6,104 | $116K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 658 | $76K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 12,621 | $73K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,922 | $72K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 803 | $67K |
| 30520 | <1% | 257 | $59K | |
| 92550 | <1% | 6,122 | $49K | |
| 69210 | <1% | 2,446 | $47K | |
| 70486 | <1% | 585 | $38K | |
| 92612 | <1% | 363 | $36K | |
| 92587 | <1% | 3,596 | $34K | |
| 31579 | <1% | 318 | $28K | |
| 92540 | <1% | 494 | $27K | |
| 95117 | <1% | 4,218 | $25K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 171 | $24K |
| 99205 | Prolong outpt/office vis | <1% | 233 | $23K |
| 30140 | <1% | 349 | $18K | |
| 92524 | <1% | 299 | $16K | |
| 92537 | <1% | 460 | $15K | |
| 99442 | <1% | 1,347 | $14K | |
| 99305 | <1% | 365 | $12K | |
| 95992 | <1% | 645 | $12K | |
| 97162 | <1% | 239 | $11K | |
| 92526 | <1% | 181 | $9K | |
| 99223 | Prolong inpt eval add15 m | <1% | 102 | $9K |
| 92610 | <1% | 231 | $8K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 557 | $8K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 403 | $7K |
| 95800 | <1% | 138 | $7K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 415 | $6K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 257 | $5K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 438 | $5K |
| 70480 | <1% | 76 | $5K | |
| 30802 | <1% | 83 | $5K | |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | <1% | 694 | $3K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 90 | $3K |
| 92553 | <1% | 200 | $3K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 102 | $3K |
| 92591 | <1% | 267 | $2K | |
| 30901 | <1% | 27 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 18 | $1K |
| 99304 | <1% | 30 | $1K | |
| 0001A | <1% | 30 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 67 | $900.20 |
| 0002A | <1% | 24 | $790.00 | |
| 95115 | <1% | 145 | $627.40 | |
| 99441 | <1% | 106 | $545.88 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 13 | $404.81 |
| 99422 | <1% | 18 | $354.57 | |
| 69200 | <1% | 16 | $138.02 | |
| 97035 | <1% | 18 | $105.10 | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 14 | $101.84 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 15 | $88.65 |
| 92567 | <1% | 14 | $63.87 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTRENKLE, GEOFFREY (OWNER)